Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of oxaliplatin when given
together with leucovorin and fluorouracil in treating young patients with advanced solid
tumors. Drugs used in chemotherapy, such as oxaliplatin, leucovorin, and fluorouracil, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill
more tumor cells.